Anxiety and depression after lung transplantation: Mirtazapine as a first-choice agent?
Fusar-Poli
Paolo
P
Matteo
Lazzaretti
L
Luca
De Marco
de M
Politi
Pierluigi
P
Cortesi
Mariachiara
M
Carboni
Valeri
V
D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy* / Q000523:psychology; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004347:Drug Interactions; D006801:Humans; D016040:Lung Transplantation / Q000523:psychology*; D008803:Mianserin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000078785:Mirtazapine; D011183:Postoperative Complications / Q000188:drug therapy* / Q000523:psychology; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy / Q000523:psychology
D000929:Antidepressive Agents, Tricyclic; D008803:Mianserin; D000078785:Mirtazapine